These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 30117751
1. In the transition from fibrinolysis to primary PCI, the HERO trials help refine STEMI ECG interpretation and Q wave analysis potentially alters future management. Wong CK, White HD. Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(1_suppl):26-33. PubMed ID: 30117751 [Abstract] [Full Text] [Related]
2. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. Wong CK, French JK, Krucoff MW, Gao W, Aylward PE, White HD. Eur Heart J; 2002 Sep; 23(18):1449-55. PubMed ID: 12208225 [Abstract] [Full Text] [Related]
6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J, Ding S, Ge H, Han Y, Guo J, Lin R, Su X, Zhang H, Chen L, He B, EARLY-MYO Investigators. Circulation; 2017 Oct 17; 136(16):1462-1473. PubMed ID: 28844990 [Abstract] [Full Text] [Related]
7. Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study. Topal DG, Lønborg J, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Holmvang L, Pedersen F, Clemmensen P, Saünamaki K, Jørgensen E, Kyhl K, Ghotbi A, Schoos MM, Göransson C, Bertelsen L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T. Circ Cardiovasc Interv; 2017 Mar 17; 10(3):. PubMed ID: 28264870 [Abstract] [Full Text] [Related]
8. Relationship between admission Q waves and microvascular injury in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Tiller C, Reindl M, Holzknecht M, Innerhofer L, Wagner M, Lechner I, Mayr A, Klug G, Bauer A, Metzler B, Reinstadler SJ. Int J Cardiol; 2019 Dec 15; 297():1-7. PubMed ID: 31629564 [Abstract] [Full Text] [Related]
9. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction. Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Bang LE, Helqvist S, Kyhl K, Køber L, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T. Circ Cardiovasc Interv; 2018 Sep 15; 11(9):e006842. PubMed ID: 30354595 [Abstract] [Full Text] [Related]
10. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry. Peiyuan H, Jingang Y, Haiyan X, Xiaojin G, Ying X, Yuan W, Wei L, Yang W, Xinran T, Ruohua Y, Chen J, Lei S, Xuan Z, Rui F, Yunqing Y, Qiuting D, Hui S, Xinxin Y, Runlin G, Yuejin Y, CAMI Registry study group. PLoS One; 2016 Sep 15; 11(11):e0165672. PubMed ID: 27812152 [Abstract] [Full Text] [Related]
12. Electrocardiogram to predict reperfusion success in late presenters with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Topal DG, Nepper-Christensen L, Lønborg J, Ahtarovski KA, Tilsted HH, Sørensen R, Pedersen F, Joshi F, Bang LE, Fakhri Y, Helqvist S, Holmvang L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T. J Electrocardiol; 2020 Sep 15; 59():74-80. PubMed ID: 32007909 [Abstract] [Full Text] [Related]
13. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Solhpour A, Chang KW, Arain SA, Balan P, Zhao Y, Loghin C, McCarthy JJ, Vernon Anderson H, Smalling RW. Catheter Cardiovasc Interv; 2016 Nov 15; 88(5):709-715. PubMed ID: 27028120 [Abstract] [Full Text] [Related]
14. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study). Welsh RC, Van de Werf F, Westerhout CM, Goldstein P, Gershlick AH, Wilcox RG, Danays T, Bluhmki E, Lopes RD, Steg PG, Armstrong PW. Am J Cardiol; 2014 Sep 15; 114(6):811-9. PubMed ID: 25108302 [Abstract] [Full Text] [Related]
15. Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons. Wong CK. Int J Cardiol; 2017 Jan 15; 227():30-36. PubMed ID: 27846459 [Abstract] [Full Text] [Related]
16. Early Q-wave morphology in prediction of reperfusion success in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention - A cardiac magnetic resonance imaging study. Topal DG, Lønborg J, Ahtarovski KA, Nepper-Christensen L, Fakhri Y, Helqvist S, Holmvang L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T. J Electrocardiol; 2020 Jan 15; 58():135-142. PubMed ID: 31869764 [Abstract] [Full Text] [Related]
17. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry. Jovin IS, Shah RM, Patel DB, Rao SV, Baklanov DV, Moussa I, Kennedy KF, Secemsky EA, Yeh RW, Kontos MC, Vetrovec GW. JACC Cardiovasc Interv; 2017 Jun 12; 10(11):1102-1111. PubMed ID: 28527778 [Abstract] [Full Text] [Related]
18. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry. Auffret V, Leurent G, Boulmier D, Bedossa M, Zabalawi A, Hacot JP, Coudert I, Filippi E, Castellant P, Rialan A, Rouault G, Druelles P, Boulanger B, Treuil J, Avez B, Le Guellec M, Gilard M, Le Breton H. Arch Cardiovasc Dis; 2016 Dec 12; 109(12):696-707. PubMed ID: 27818120 [Abstract] [Full Text] [Related]
19. ST-segment resolution with bivalirudin versus heparin and routine glycoprotein IIb/IIIa inhibitors started in the ambulance in ST-segment elevation myocardial infarction patients transported for primary percutaneous coronary intervention: The EUROMAX ST-segment resolution substudy. Van't Hof A, Giannini F, Ten Berg J, Tolsma R, Clemmensen P, Bernstein D, Coste P, Goldstein P, Zeymer U, Hamm C, Deliargyris E, Steg PG. Eur Heart J Acute Cardiovasc Care; 2017 Aug 12; 6(5):404-411. PubMed ID: 26250825 [Abstract] [Full Text] [Related]
20. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Armstrong PW, Fu Y, Westerhout CM, Hudson MP, Mahaffey KW, White HD, Todaro TG, Adams PX, Aylward PE, Granger CB. J Am Coll Cardiol; 2009 Apr 28; 53(17):1503-9. PubMed ID: 19389560 [Abstract] [Full Text] [Related] Page: [Next] [New Search]